{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:25:00Z","timestamp":1793993100746,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["SBGJ202001008"],"award-info":[{"award-number":["SBGJ202001008"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.isci.2026.115571","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:18:04Z","timestamp":1775135884000},"page":"115571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal ctDNA tracking by low-pass whole-genome sequencing predicts CAR-T outcomes in B-cell lymphomas"],"prefix":"10.1016","volume":"29","author":[{"given":"Sijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8515-8189","authenticated-orcid":false,"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115571_bib1","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/bloodadvances.2019000151","article-title":"Tisagenlecleucel in relapsed\/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion","volume":"3","author":"Bishop","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.115571_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1\u20132 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood.2019001694","article-title":"Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma","volume":"134","author":"Frigault","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115571_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.115571_bib5","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2026.115571_bib6","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1200\/JCO.23.02786","article-title":"Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium","volume":"42","author":"Jain","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.20892\/j.issn.2095-3941.2019.0144","article-title":"The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy","volume":"16","author":"Jia","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.isci.2026.115571_bib8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1158\/1078-0432.CCR-19-3467","article-title":"Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers","volume":"26","author":"Parikh","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.115571_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pathol-050520-044652","article-title":"Molecular Monitoring of Lymphomas","volume":"18","author":"Schroers-Martin","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2026.115571_bib10","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood.2021012852","article-title":"Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma","volume":"139","author":"Meriranta","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115571_bib11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41375-022-01618-w","article-title":"Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research","volume":"36","author":"Lauer","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.115571_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-20-2558","article-title":"Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study","volume":"27","author":"Rivas-Delgado","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.115571_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/jamaoncol.2024.6144","article-title":"Circulating tumor DNA as measurable residual disease in aggressive B-cell lymphoma: a narrative review","volume":"11","author":"Roschewski","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib14","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41587-021-00981-w","article-title":"Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA","volume":"39","author":"Kurtz","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.115571_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41375-022-01803-x","article-title":"Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET\/CT","volume":"37","author":"Jim\u00e9nez-Ubieto","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.115571_bib16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","article-title":"Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring","volume":"26","author":"Zviran","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115571_bib17","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1038\/s41467-022-32598-1","article-title":"Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA","volume":"13","author":"Wan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115571_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood.2022015601","article-title":"Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma","volume":"140","author":"Cherng","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115571_bib19","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/bloodadvances.2020003039","article-title":"The landscape of copy number variations in classical hodgkin lymphoma: a joint KU leuven and LYSA study on cell-free DNA","volume":"5","author":"Buedts","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.115571_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2016.12.004","article-title":"Single-chromosome gains commonly function as tumor suppressors","volume":"31","author":"Sheltzer","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.115571_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104291","article-title":"Trip13 depletion in liver cancer induces a lipogenic response contributing to Plin2-dependent mitotic cell death","volume":"9","author":"Rios Garcia","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.115571_bib22","article-title":"Risk assessment with ultra-low-pass whole-genome sequencing of cell-free DNA for large B-cell lymphoma","volume":"9","author":"Zhao","year":"2025","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib24","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1182\/blood-2023-181351","article-title":"Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse\/Refractory Non-Hodgkin Lymphoma: Real-World Data in Chinese Population","volume":"142","author":"Yan","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115571_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115571_bib26","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115571_bib27","first-page":"2661","article-title":"CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study","volume":"110","author":"Magni","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2026.115571_bib28","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor DNA measurements As early outcome predictors in diffuse large B-cell lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15363","article-title":"Short single-stranded DNA degradation products augment the activation of toll-like receptor 9","volume":"8","author":"Pohar","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115571_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29968","article-title":"Imaging recommendations in pediatric lymphoma: a COG diagnostic imaging committee\/SPR oncology committee white paper","volume":"70","author":"Mhlanga","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.isci.2026.115571_bib31","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1200\/JCO.21.00377","article-title":"Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial","volume":"39","author":"Frank","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41408-023-00904-9","article-title":"Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma","volume":"13","author":"Qiang","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.isci.2026.115571_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood.2024025563","article-title":"Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation","volume":"145","author":"Kumar","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115571_bib34","doi-asserted-by":"crossref","first-page":"30.e1","DOI":"10.1016\/j.jtct.2021.10.007","article-title":"Assessing CAR T-cell therapy response using genome-wide sequencing of cell-free DNA in patients with B-cell lymphomas","volume":"28","author":"Goodman","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.isci.2026.115571_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1341997","article-title":"Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers","volume":"14","author":"Chang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.115571_bib36","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.115571_bib37","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226009466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226009466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:22:37Z","timestamp":1781832157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226009466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2589004226009466"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115571","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal ctDNA tracking by low-pass whole-genome sequencing predicts CAR-T outcomes in B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115571"}}